{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:18:33Z","timestamp":1759342713181},"reference-count":20,"publisher":"Informa UK Limited","issue":"9","funder":[{"name":"Spanish MICINN","award":["CTQ2011-29549-C02-01"],"award-info":[{"award-number":["CTQ2011-29549-C02-01"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Med. Chem."],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.4155\/fmc.14.41","type":"journal-article","created":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T13:52:20Z","timestamp":1406555540000},"page":"975-978","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Glucocerebrosidase Inhibitors: Future Drugs for the Treatment of Gaucher Disease?"],"prefix":"10.1080","volume":"6","author":[{"given":"Ana","family":"Trapero","sequence":"first","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Department of Biomedicinal Chemistry, Institut de Qu\u00edmica Avan\u00e7ada de Catalunya (IQAC\u2013CSIC), Jordi Girona 18-26, 08034Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amadeu","family":"Llebaria","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Department of Biomedicinal Chemistry, Institut de Qu\u00edmica Avan\u00e7ada de Catalunya (IQAC\u2013CSIC), Jordi Girona 18-26, 08034Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,7,28]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1423"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61522-6"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-002-8458-y"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-010-9095-5"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2004.08.015"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028013500469"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2014.01.005"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm301557k"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.200900036"},{"key":"e_1_3_2_11_1","first-page":"7","article-title":"Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities","volume":"3","author":"Suzuki Y","year":"2009","unstructured":"Suzuki Y , OgawaS, SakakibaraY. Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities. Perspect. Med. Chem.3, 7\u201319 (2009).","journal-title":"Perspect. Med. Chem."},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.13.14"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2011.569162"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm300063b"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2760"},{"key":"e_1_3_2_16_1","unstructured":"Amicus Therapeutics announces preliminary results of Phase II study with plicera for Gaucher disease. http:\/\/ir.amicustherapeutics.com\/ReleaseDetail.cfm?ReleaseID=413437"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.012393"},{"key":"e_1_3_2_18_1","unstructured":"Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01463215"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3831"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.008185"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2013.03.006"}],"container-title":["Future Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/fmc.14.41","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:49:24Z","timestamp":1716493764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/fmc.14.41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.4155\/fmc.14.41"],"URL":"https:\/\/doi.org\/10.4155\/fmc.14.41","relation":{},"ISSN":["1756-8919","1756-8927"],"issn-type":[{"value":"1756-8919","type":"print"},{"value":"1756-8927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-07-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}